Balyasny Asset Management’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.5M Sell
631,669
-86,434
-12% -$3.65M 0.04% 570
2026
Q2
$19.9M Buy
718,103
+452,939
+171% +$10.7M 0.02% 714
2026
Q1
$5.72M Buy
+265,164
New +$4.89M 0.01% 1308

Other funds holding PLSE

Balyasny Asset Management's PLSE Position: Q3 2026 in Review

Balyasny Asset Management reduced its Pulse Biosciences (PLSE) stake by 12% in Q3 2026, selling an estimated $3.65M and leaving 631,669 shares worth $31.5M. The position accounts for 0.04% of the portfolio, ranked #570.

Balyasny Asset Management first reported a position in PLSE in Q1 2026 and has held it in 3 quarters since. 142 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • Balyasny Asset Management held 631,669 shares of Pulse Biosciences worth $31.5M as of Q3 2026.
  • Balyasny Asset Management sold 86,434 Pulse Biosciences shares in Q3 2026, an estimated $3.65M.
  • Pulse Biosciences made up 0.04% of Balyasny Asset Management's portfolio in Q3 2026, its #570 holding.
  • Balyasny Asset Management first reported a position in Pulse Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 142 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.